image
Revolution Medicines, Inc. RVMD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 36.56
-0.544 %
$ 6.8 B
Market Cap
-10.21
P/E
Price Target Average
75.33%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
--5.46%
Net Income Estimate
24.41%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Revolution Medicines, Inc.
image
Wall Street analysts predict an average 1-year price target for RVMD of $64.1 , with forecasts ranging from a low of $55 to a high of $82 .
RVMD Lowest Price Target Wall Street Target
55 USD 50.44%
RVMD Average Price Target Wall Street Target
64.1 USD 75.33%
RVMD Highest Price Target Wall Street Target
82 USD 124.29%
Price
Max Price Target
Min Price Target
Average Price Target
9090808070706060505040403030Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart RVMD

image
$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RVMD

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)($900.0m)($900.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RVMD

image
$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)20202020202120212022202220232023202420242025202520262026202720272028202820292029